Recap last night trades
kenttkw
I had something to attend to just now after telephone conversation, so no time to write about DNDN.
DNDN is down now @15.20
I have yet to see DNDN to break new low that is 14.82
morsid, I cut loss DYN last night after found out negative news
Bought 600 9.96 and sold 9.59
Tonight the price down 9.75 now.
ONSM look interesting now, looking for 2.40
I also bought FMD 200 @37.90, now 38.80
Upgraded by JP Morgan from "neutral to overweight"
kenttkw
If your google ok, please some comments
7 comments:
AVNR - i'm watching and waiting to see it hit the next support of 3.20. look still active.
AVNR - support at 3.35 still monitoring.
morsid, those who got faint heart and without real time total view and real time chart cannot trade FMD. I can't see price change on poems. I have sold 38.60.
Will go in again below 37.00
AVNR no longer on my radar screen
Ther are only 2 stocks below 5.00 on my radar screen. ONT & ONSM
I q to buy ONSM at 2.40 @3K
Another q with big volume 80k at 2.39
DNDN SAGA
HealthShares(TM) Inc., an investment company with a series of 20 underlying fund portfolios, today announced it has been informed by Standard & Poor's, the calculating agent for the HealthShares(TM) Indexes, that effective at the opening of trading on Monday April 30, 2007, Integra Life Sciences (Nasdaq: IART - News) will replace Merck Serono (NYSE: SRA - News) in the HealthShares(TM) Dermatology and Wound Care Index; and XOMA Ltd. (Nasdaq: XOMA - News) will replace Merck Serono in the HealthShares(TM) Emerging Cancer Index. Additionally, Dendreon Corp. (Nasdaq: DNDN - News) will replace Merck Serono in the HealthShares(TM) Composite Index.
Any stock listed under Standard & Poor’s is considered an upgrading. DNDN panic selling was triggered yesterday because of a letter published in media regarding DNDN drug Provenge claimed by the doctor is unsafe to be consumed by cancer patients. There are too many negative comments by the Broking Houses, Analysts and doctors on DNDN Provenge. It isn’t strange to me that the media stream were used by Smart Money to instil fears to traders and investor of DNDN to sell the shares down to current low price $15.00+.
$1 Billion in Sales
Provenge will be Dendreon's first product and may generate $1 billion a year in sales if approved by the FDA. Dendreon, founded in 1992, is trying to be the first drugmaker to market a new class of experimental medicines scientists are developing that stimulate the body's immune system to attack cancer.
Hedge Funds & short-sellers may be betting that the FDA won't go along with the panel because of the conflicting clinical trial results. Dendreon's own statistical consultant told the advisory panel on March 29 that the research data is ``less than perfect.''
My view and observation of the above
They were too many nay-sayer sceptical about the products safety. We are living in the world Lies. People lie to get what they want and to hide the truth from public, traders and investors. Lies have become institutionalized and practice by the Rich, Professionals, Smart Money and Political Leaders across the globe. Lies are the way of life of many Rich, Professionals and Political leaders. Click on the video link Smart Money Drive the Market for more information.
Hedge Funds, traders and institutional investors who missed the 2 previous rallies will spread negative rumours through media, broadcasting and internet. They will buy the shares at a discount from the week holders that were duped into selling their shares out of fear.
However, when ever there is a sell off, the shares price of DNDN will bounce upon touching 14.80+ and revert above $15.00. I have been observing these occurred on 3 occasions. WHY?
The volume traded tonight at 1.22 am is about 5.9 millions which are about 200% lesser than normal trading day for DNDN. Therefore, I presumed that the selling for tonight could be the work of short sellers and few of the weak holders. The selling had dried out and the smart money could have accumulated from 14.80 to 15.40 before they begin another rally next week. DNDN is good for traders in and out on weekly basis.
The share price of 14.80 to 15.40 could be the fair value for DNDN at this moment before the approval. For that being said, I cannot rule out that share price can go below 14.84 and if this support is breached the next support will be at 14.41.
There are too many uncertainties and possibilities for DNDN. Please take note that DNDN could turn ugly if FDA results are not in favour for their product Provenge.
Positive results with 40% short interest and smart money funds would push the share price double or triple from 15.00.
Risks vs Rewards
I will buy 200 or 300 shares in the low fifteenth either tonight or on Monday in anticipating there could be a rally next week.
Typo error on the selling price
morsid, I cut loss DYN last night after found out negative news
Bought 600 9.96 and sold 9.95 not 9.59, last night low was 9.86
Tonight the price down 9.75 now.
FDA Review DNDN Provenge May 15
Prostate cancer treatment
A new prostate cancer procedure is giving new hope to patients.
Clinical trials are underway for a new drug called provenge.
It works like a vaccine. Patients have their blood drawn and immune cells are mixed with a prostate cancer protein and a stimulant to make the immune system more active. The new cells are then infused back into the patient.
In trials, the therapy tripled survival rates in the men who received it. Unlike chemo and radiation, provenge is working all the time.
The therapy was given three times two weeks apart.
Doctors say side effects are minimal, especially compared to other options chemo and radiation. The only known side effects are mild flu-like symptoms.
The food and drug administration will review provenge in May.
Provenge will be Dendreon's first product and may generate $1 billion a year in sales if approved by the FDA.
Approval by FDA plus 40% short covering by hedge funds could soar double or triple DNDN share price from here.
I feel that hedge funds, broking houses and institutional investors intentionally talked down on DNDN to con traders and investing public to sell their shares and bring down the price so that they can accumulate as much as they can at low price.
Click on the video link DNDN Provenge Prostate Cancer Treatment
Click on the small blue box next to the date to view the video.
Post a Comment